Related Experiment Video
Updated: Mar 8, 2026

Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
Published on: December 21, 2011
Excessive angiogenesis associated with psoriasis as a cause for cardiovascular ischaemia
1Manchester Academic Health Science Centre, Department of Dermatology, The University of Manchester, Manchester, UK.
Insights
Psoriasis patients show increased angiogenesis, driven by vascular endothelial growth factor (VEGF). This process may link skin disease to cardiovascular events and offer new therapeutic targets.
Area of Science:
- Dermatology and Cardiovascular Research
Background:
- Psoriasis affects 2-3% of the UK population, causing significant quality of life impairment.
- Psoriasis is linked to cardiovascular comorbidity and metabolic syndrome.
- Angiogenesis is implicated in psoriasis pathogenesis and atherosclerosis development.
Purpose of the Study:
- To explore the role of vascular endothelial growth factor (VEGF)-mediated angiogenesis in psoriasis.
- To investigate angiogenesis as a potential marker for systemic vascular pathology in psoriasis patients.
- To examine VEGF-mediated angiogenesis as a therapeutic target for cardiovascular events in psoriasis.
Main Methods:
- This viewpoint study reviews existing research on angiogenesis in psoriasis.
- It focuses on the role of vascular endothelial growth factor (VEGF).
Main Results:
- Vascular endothelial growth factor (VEGF) is upregulated in psoriasis.
- Pathological angiogenesis, mediated by VEGF, is a key factor in psoriasis.
- Cutaneous angiogenesis may serve as a marker for systemic vascular pathology.
Conclusions:
- VEGF-mediated angiogenesis is a significant factor in psoriasis.
- It may contribute to cardiovascular events in psoriasis patients.
- Targeting angiogenesis presents a novel therapeutic avenue for psoriasis and associated cardiovascular conditions.
Abstract:
Psoriasis, a common disease affecting 2%-3% of the UK population, produces significant impairment of quality of life and is an immense burden on sufferers and their families. Psoriasis is associated with significant cardiovascular comorbidity and the metabolic syndrome. Angiogenesis, a relatively under-researched component of psoriasis, is a key factor in pathogenesis of psoriasis and also contributes to the development of atherosclerosis. Vascular endothelial growth factor (VEGF) is a well-established mediator of pathological angiogenesis which is upregulated in psoriasis. It is possible that, in patients with psoriasis, cutaneous angiogenesis may be both a marker for systemic vascular pathology and a novel therapeutic target. In this viewpoint study, the role of VEGF-mediated angiogenesis as a cause for cardiovascular events in patients with psoriasis is explored.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Regulation of Angiogenesis and Blood Supply
Atherosclerosis I: Introduction
Mechanism of Angiogenesis

